Five roles, one loop that never stops moving.
This is the signature of how Ibhar works: not a single tool, but a loop that connects every team with a stake in infection outcomes — closing the distance between what is observed and what is done about it.
Prevention
Daily audits of hand hygiene, bundles, sterilization, environment and post-surgery follow-up.
Detection
Continuous CDC-rule checks on vitals, symptoms and cultures flag suspected HAIs, MDROs and outbreaks.
Investigation
Culture reports with MIC tables and therapeutic index. Alerts reach the duty ICN and treating clinician.
Prescription
Antibiograms guide empirical therapy. Suggested dosing, approvals and pharmacist time-outs keep prescribing governed.
Cessation
IV-to-oral conversion, stop dates, discharge antibiotics and outcome review, logged for the HICC.
Three connected capabilities, not three separate products.
Infection prevention, clinical microbiology and antimicrobial stewardship are usually run as separate workstreams. Ibhar treats them as one connected system, with each capability informing the others.
Observe risk as it emerges
- Mobile-first HAI & device-associated infection surveillance
- Hand hygiene compliance and audit workflows
- Environmental audits, vaccination and needle-stick tracking where implemented
Turn results into understanding
- Structured culture & antimicrobial susceptibility workflows
- Hospital-specific antibiograms and MIC guiding tables
- Laboratory and instrument integration, scoped to each implementation
Guide stewardship, support clinicians
- Antibiotic utilisation analysis and DDD/DOT indicators
- Stewardship review workflows, time-outs and policy tracking
- Antibiogram-informed guidance to support — not replace — prescriber judgement
Prevention, diagnosis & treatment — connected end to end.
The programme involves every stakeholder — administrators, IPC nurses, microbiologists, pharmacologists and clinicians — on one platform, from prevention to post-treatment.
Prevention & Surveillance
Hand hygiene, environment, bundles, prophylaxis and post-surgery follow-up.
Detection & Rules
CDC-rule detection across vitals, symptoms and cultures — MDRO flags and early outbreak signals.
Investigation & Microbiology
MIC tables, therapeutic index and escalation straight to the treating clinician.
Prescription & Stewardship
Antibiograms for empirical therapy, approval workflows and adherence monitoring.
Outcomes & Analytics
HAI rates and compliance trends, antibiotic usage with DDD/DOT, KPIs and escalations.
"Hospitals record infections. Few learn from them."— The problem Ibhar was built to close
A single observation, followed through five roles.
An illustrative pathway — the exact steps supported depend on each hospital's configuration and integrations.
Logs a surveillance observation
A device-associated infection indicator is recorded during a routine round, mobile-first and in real time.
Links the culture result
Susceptibility data is structured against the hospital's antibiogram, clarifying the organism and resistance pattern.
Sees the result where it matters
The relevant finding becomes visible at the point of a treatment decision, rather than buried in a separate report.
Reviews antimicrobial use
A stewardship time-out checks the regimen against hospital policy and the antibiogram-informed guidance.
Reviews the outcome
The case feeds into institutional learning — informing policy, training and the next surveillance cycle.